緑内障用房水シャントデバイス市場：材料、エンドユーザー、手術タイプ別-2025-2030年の世界予測

緑内障用房水シャントデバイス市場は、2023年に4億6,382万米ドルと評価され、2024年には4億9,282万米ドルに達すると予測され、CAGR 5.54％で成長し、2030年には6億7,682万米ドルになると予測されています。

緑内障用房水シャントデバイス市場には、緑内障患者の眼圧管理に役立つよう設計された医療機器が含まれ、過剰な房水を前房から排出できるようにします。これらのシャントデバイスは、薬物療法が不十分な患者や手術が失敗した患者にとって極めて重要であり、眼科ヘルスケアに不可欠な要素となっています。これらの装置の必要性は、人口の高齢化と北米や欧州のような地域における早期診断に対する意識の高まりに起因する緑内障の有病率の上昇から生じています。最終用途は病院、眼科クリニック、外来手術センターなど多岐にわたる。

市場の洞察によると、シャント設計の技術的進歩や新興市場での採用率の増加が成長に拍車をかけています。しかし、同市場は術後合併症の可能性、シャントデバイスの高コスト、規制当局の厳しい承認といった課題にも直面しています。主な成長要因としては、ヘルスケア支出の増加、社会的認知度の向上、眼科医療に対する政府の取り組みの拡大などが挙げられます。さらに、生体適合性の高い素材や非侵襲的な手術手技を重視した技術革新は、潜在的なビジネスチャンスをもたらしています。企業は、有効性と安全性のプロファイルを改善した製品の提供を強化することで、これらのアンメット・ニーズをターゲットにすることができます。

しかし、こうした医療機器に関連する高コストや潜在的な副作用、規制上のハードルが、市場の成長を妨げています。こうした制約を克服するには、研究開発を通じて製造コストの削減と製品の有効性の向上に注力することが極めて重要です。技術革新のための最良の分野は、眼圧のリアルタイムモニタリングと患者の個別ケアを可能にする、よりスマートなセンサー付きシャントデバイスの開発です。未診断の患者が多いアジア市場での需要の高さなど、地域による市場の違いを理解することで、企業は成長機会を効果的に活用することができます。その結果、企業はより良い市場浸透と消費者の信頼構築のために、地域拡大や現地のヘルスケアプロバイダーとの連携に投資すべきです。

市場力学：急速に進化する緑内障用房水シャントデバイス市場における主要市場インサイトの解明

緑内障用房水シャントデバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の緑内障有病率の増加と老年人口の増加が房水シャントデバイスの需要を牽引
  • より効果的で安全な緑内障治療につながる眼科機器の技術進歩
  • 緑内障の早期診断と治療率を高める治療費と啓発活動の増加
  • 好意的な償還政策と政府の支援により、緑内障シャント装置へのアクセスが向上
• 市場抑制要因
  • 緑内障の代替治療の競合
  • 術後合併症のリスクと進歩にもかかわらず
• 市場機会
  • 治療効果と患者の転帰を向上させる緑内障シャント装置の革新的進歩
  • 低侵襲緑内障治療に対する市場の需要拡大が房水シャント装置の成長を促進
  • 緑内障治療のイノベーションを促進するための医療機器企業とヘルスケア機関の連携
• 市場の課題
  • 緑内障シャント装置への患者アクセスを制限する高コストと償還の問題
  • 複雑な薬事承認と地域によって異なる基準が市場成長の妨げに

ポーターの5つの力：緑内障用房水シャントデバイス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：緑内障用房水シャントデバイス市場における外部からの影響の把握

外部マクロ環境要因は、緑内障用房水シャントデバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析緑内障用房水シャントデバイス市場における競合情勢の把握

緑内障用房水シャントデバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス緑内障用房水シャントデバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、緑内障用房水シャントデバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨緑内障用房水シャントデバイス市場における成功への道筋を描く

緑内障用房水シャントデバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 緑内障の罹患率の増加と高齢者人口の増加により、房水シャント装置の需要が世界的に高まっています。
    • 眼科機器の技術的進歩により、緑内障治療がより効果的かつ安全になる
    • ヘルスケア費の増加と啓発活動により、緑内障の早期診断と治療率が上昇
    • 有利な償還政策と政府の支援により、緑内障房水シャント装置のアクセシビリティが向上
  • 抑制要因
    • 緑内障の代替治療の競合
    • 術後合併症のリスクがあり、進歩にもかかわらず
  • 機会
    • 緑内障房水シャントデバイスの革新的な進歩により治療効果と患者の転帰が向上
    • 低侵襲性緑内障治療の市場需要拡大が房水シャント装置の成長を牽引
    • 緑内障治療の革新を促進する医療機器企業とヘルスケア機関の連携
  • 課題
    • 高額な費用と償還の問題により、緑内障房水シャント装置への患者のアクセスが制限されている
    • 複雑な規制承認と地域ごとの異なる基準が市場の成長を妨げている
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 緑内障用房水シャントデバイス市場：素材別

• ポリプロピレン
• シリコーン

第7章 緑内障用房水シャントデバイス市場：エンドユーザー別

• 外来手術センター
• 病院
• 眼科クリニック

第8章 緑内障用房水シャントデバイス市場手術の種類別

• 緑内障ドレナージ装置手術
• 低侵襲緑内障手術
• 非穿孔性緑内障手術

第9章 南北アメリカの緑内障用房水シャントデバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の緑内障用房水シャントデバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの緑内障用房水シャントデバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. AbbVie Inc.
• 2. Alcon Inc.
• 3. Allergan
• 4. Bausch & Lomb Incorporated
• 5. Carl Zeiss Meditec AG
• 6. Glaukos Corporation
• 7. Johnson & Johnson Vision Care Inc.
• 8. MicroOptx Inc.
• 9. New World Medical Inc.
• 10. Nova Eye Medical Limited
• 11. Ocular Therapeutix, Inc.
• 12. Reichert, Inc.
• 13. Santen Pharmaceutical Co., Ltd.
• 14. Staar Surgical Company

LIST OF FIGURES

• FIGURE 1. GLAUCOMA AQUEOUS SHUNT DEVICE MARKET RESEARCH PROCESS
• FIGURE 2. GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. GLAUCOMA AQUEOUS SHUNT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GLAUCOMA AQUEOUS SHUNT DEVICE MARKET DYNAMICS
• TABLE 7. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SILICONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY GLAUCOMA DRAINAGE DEVICE SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MINIMALLY INVASIVE GLAUCOMA SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY NON-PENETRATING GLAUCOMA SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 29. CANADA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. CANADA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 46. CHINA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. CHINA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 49. INDIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. INDIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 101. ITALY GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. ITALY GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 113. POLAND GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. POLAND GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 116. QATAR GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. QATAR GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SIZE, BY SURGERY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. GLAUCOMA AQUEOUS SHUNT DEVICE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. GLAUCOMA AQUEOUS SHUNT DEVICE MARKET, FPNV POSITIONING MATRIX, 2023

The Glaucoma Aqueous Shunt Device Market was valued at USD 463.82 million in 2023, expected to reach USD 492.82 million in 2024, and is projected to grow at a CAGR of 5.54%, to USD 676.82 million by 2030.

The Glaucoma Aqueous Shunt Device market involves medical devices designed to help manage intraocular pressure in patients with glaucoma by allowing excess aqueous humor fluid to drain from the anterior chamber of the eye. These shunt devices are crucial for patients where medication is inadequate or surgery has failed, thus serving as a vital component of ocular healthcare. The necessity of these devices stems from the escalating prevalence of glaucoma, attributed to an aging population and increased awareness for early diagnosis in regions like North America and Europe. Key applications reside in facilitating targeted treatment for different types of glaucoma patients, and the end-use scope spans hospitals, ophthalmic clinics, and outpatient surgical centers.

Market insights suggest a growth spurred by technological advancements in shunt designs and increased adoption rates in emerging markets. However, the market also faces challenges such as potential post-surgical complications, high costs of shunt devices, and stringent regulatory approvals. Key growth factors include rising healthcare expenditures, increased public awareness, and expanding government initiatives for eye care. Furthermore, innovations emphasizing biocompatible materials and non-invasive surgical techniques present potential opportunities. Companies can target these unmet needs by enhancing product offerings with improvements in efficacy and safety profiles.

However, market growth is impeded by high costs and potential side effects associated with these devices, as well as regulatory hurdles. To overcome these limitations, focusing on reducing manufacturing costs and enhancing product efficacy through R&D can be pivotal. The best areas for innovation encompass developing smarter, sensor-equipped shunt devices that allow real-time monitoring of intraocular pressure and personalized patient care. Understanding regional market variations, such as the high demand in Asian markets driven by a large pool of undiagnosed patients, can position businesses to leverage growth opportunities effectively. Consequently, firms should invest in regional expansion and collaboration with local healthcare providers for better market penetration and consumer trust building.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glaucoma Aqueous Shunt Device Market

The Glaucoma Aqueous Shunt Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of glaucoma and rising geriatric population globally driving demand for aqueous shunt devices
  • Technological advancements in ophthalmic devices leading to more effective and safer glaucoma treatments
  • Growing healthcare expenditure and awareness initiatives boosting early glaucoma diagnosis and treatment rates
  • Favorable reimbursement policies and government support enhancing accessibility of glaucoma aqueous shunt devices
• Market Restraints
  • Competition of alternative treatments for glaucoma
  • Risk of postoperative complications and despite advancements
• Market Opportunities
  • Innovative advancements in Glaucoma aqueous shunt devices enhancing treatment efficacy and patient outcomes
  • Expanding market demand for minimally invasive Glaucoma treatments driving growth of aqueous shunt devices
  • Collaborations between medical device companies and healthcare institutions to foster Glaucoma treatment innovations
• Market Challenges
  • High costs and reimbursement issues limiting patient access to glaucoma aqueous shunt devices
  • Complex regulatory approvals and varying standards across different regions hindering market growth

Porter's Five Forces: A Strategic Tool for Navigating the Glaucoma Aqueous Shunt Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glaucoma Aqueous Shunt Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glaucoma Aqueous Shunt Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glaucoma Aqueous Shunt Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glaucoma Aqueous Shunt Device Market

A detailed market share analysis in the Glaucoma Aqueous Shunt Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glaucoma Aqueous Shunt Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glaucoma Aqueous Shunt Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glaucoma Aqueous Shunt Device Market

A strategic analysis of the Glaucoma Aqueous Shunt Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glaucoma Aqueous Shunt Device Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Inc., Allergan, Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Glaukos Corporation, Johnson & Johnson Vision Care Inc., MicroOptx Inc., New World Medical Inc., Nova Eye Medical Limited, Ocular Therapeutix, Inc., Reichert, Inc., Santen Pharmaceutical Co., Ltd., and Staar Surgical Company.

Market Segmentation & Coverage

This research report categorizes the Glaucoma Aqueous Shunt Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Material, market is studied across Polypropylene and Silicone.
• Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Ophthalmic Clinics.
• Based on Surgery Type, market is studied across Glaucoma Drainage Device Surgery, Minimally Invasive Glaucoma Surgery, and Non-Penetrating Glaucoma Surgery.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of glaucoma and rising geriatric population globally driving demand for aqueous shunt devices
    • 5.1.1.2. Technological advancements in ophthalmic devices leading to more effective and safer glaucoma treatments
    • 5.1.1.3. Growing healthcare expenditure and awareness initiatives boosting early glaucoma diagnosis and treatment rates
    • 5.1.1.4. Favorable reimbursement policies and government support enhancing accessibility of glaucoma aqueous shunt devices
  • 5.1.2. Restraints
    • 5.1.2.1. Competition of alternative treatments for glaucoma
    • 5.1.2.2. Risk of postoperative complications and despite advancements

• 5.1.3. Opportunities
  • 5.1.3.1. Innovative advancements in Glaucoma aqueous shunt devices enhancing treatment efficacy and patient outcomes
  • 5.1.3.2. Expanding market demand for minimally invasive Glaucoma treatments driving growth of aqueous shunt devices
  • 5.1.3.3. Collaborations between medical device companies and healthcare institutions to foster Glaucoma treatment innovations
• 5.1.4. Challenges
  • 5.1.4.1. High costs and reimbursement issues limiting patient access to glaucoma aqueous shunt devices
  • 5.1.4.2. Complex regulatory approvals and varying standards across different regions hindering market growth
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Glaucoma Aqueous Shunt Device Market, by Material

• 6.1. Introduction
• 6.2. Polypropylene
• 6.3. Silicone

7. Glaucoma Aqueous Shunt Device Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals
• 7.4. Ophthalmic Clinics

8. Glaucoma Aqueous Shunt Device Market, by Surgery Type

• 8.1. Introduction
• 8.2. Glaucoma Drainage Device Surgery
• 8.3. Minimally Invasive Glaucoma Surgery
• 8.4. Non-Penetrating Glaucoma Surgery

9. Americas Glaucoma Aqueous Shunt Device Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Glaucoma Aqueous Shunt Device Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Glaucoma Aqueous Shunt Device Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Alcon Inc.
• 3. Allergan
• 4. Bausch & Lomb Incorporated
• 5. Carl Zeiss Meditec AG
• 6. Glaukos Corporation
• 7. Johnson & Johnson Vision Care Inc.
• 8. MicroOptx Inc.
• 9. New World Medical Inc.
• 10. Nova Eye Medical Limited
• 11. Ocular Therapeutix, Inc.
• 12. Reichert, Inc.
• 13. Santen Pharmaceutical Co., Ltd.
• 14. Staar Surgical Company